Klebsiella pneumoniae: development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumonia

Objectives: To identify the mechanism of in vivo development of carbapenem resistance in Klebsiella pneumoniae.Methods: Seven sequential isolates of K. pneumoniae were obtained from twin infants with pneumonia. Antimicrobial susceptibility testing was performed by agar dilution. Carbapenemases inclu...

Full description

Bibliographic Details
Main Authors: Junying eZhu, Baixing eDing, Xiaogang eXu, Demei eZhu, fan eYang, Hong eZhang, Fupin eHu
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-12-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01399/full
_version_ 1818434277214257152
author Junying eZhu
Baixing eDing
Xiaogang eXu
Demei eZhu
fan eYang
Hong eZhang
Fupin eHu
author_facet Junying eZhu
Baixing eDing
Xiaogang eXu
Demei eZhu
fan eYang
Hong eZhang
Fupin eHu
author_sort Junying eZhu
collection DOAJ
description Objectives: To identify the mechanism of in vivo development of carbapenem resistance in Klebsiella pneumoniae.Methods: Seven sequential isolates of K. pneumoniae were obtained from twin infants with pneumonia. Antimicrobial susceptibility testing was performed by agar dilution. Carbapenemases including KPC and ML were initially screened using phenotypic methods, and carbapenemase-encoding genes were identified by PCR and amplicon sequencing. Plasmids of all clinical isolates and the conjugants of resistant isolates were estimated by S1 pulsed-field gel electrophoresis (PFGE). Molecular typing were conducted by PFGE of XbaI-digested genomic DNA and multilocus sequence typing (MLST). Results: For old brother, the first and third isolates were susceptible to meropenem, whereas the second and fourth isolates were resistant (MICs 16 mg/L). The first and second isolates from the young brother were susceptible to meropenem whereas the third isolate was resistant. All the resistant isolates produced NDM-1 metallo--lactamase. PFGE of XbaI-digested DNA revealed identical patterns for all the 7 isolates. All the isolates had the same sequence type named sequence type 37 (ST37). Conclusions: To our knowledge, this is the first documented case of development of carbapenem resistance in vivo mediated by NDM-1 metallo-b-lactamase in K. pneumoniae during treatment of pneumonia with meropenem.
first_indexed 2024-12-14T16:34:26Z
format Article
id doaj.art-2219fa22fd6041718af0cf465f2acbf9
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-14T16:34:26Z
publishDate 2015-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-2219fa22fd6041718af0cf465f2acbf92022-12-21T22:54:31ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2015-12-01610.3389/fmicb.2015.01399160008Klebsiella pneumoniae: development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumoniaJunying eZhu0Baixing eDing1Xiaogang eXu2Demei eZhu3fan eYang4Hong eZhang5Fupin eHu6Children’s Hospital of Shanghai, Jiaotong UniversityHuashan Hospital, Fudan UniversityHuashan Hospital, Fudan UniversityHuashan Hospital, Fudan UniversityHuashan Hospital, Fudan UniversityChildren’s Hospital of Shanghai, Jiaotong UniversityHuashan Hospital, Fudan UniversityObjectives: To identify the mechanism of in vivo development of carbapenem resistance in Klebsiella pneumoniae.Methods: Seven sequential isolates of K. pneumoniae were obtained from twin infants with pneumonia. Antimicrobial susceptibility testing was performed by agar dilution. Carbapenemases including KPC and ML were initially screened using phenotypic methods, and carbapenemase-encoding genes were identified by PCR and amplicon sequencing. Plasmids of all clinical isolates and the conjugants of resistant isolates were estimated by S1 pulsed-field gel electrophoresis (PFGE). Molecular typing were conducted by PFGE of XbaI-digested genomic DNA and multilocus sequence typing (MLST). Results: For old brother, the first and third isolates were susceptible to meropenem, whereas the second and fourth isolates were resistant (MICs 16 mg/L). The first and second isolates from the young brother were susceptible to meropenem whereas the third isolate was resistant. All the resistant isolates produced NDM-1 metallo--lactamase. PFGE of XbaI-digested DNA revealed identical patterns for all the 7 isolates. All the isolates had the same sequence type named sequence type 37 (ST37). Conclusions: To our knowledge, this is the first documented case of development of carbapenem resistance in vivo mediated by NDM-1 metallo-b-lactamase in K. pneumoniae during treatment of pneumonia with meropenem.http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01399/fullin vivoKlebsiella pneumoniae;NDM-1 Metallo--Lactamase;Development of Carbapenem Resistance;Meropenem;
spellingShingle Junying eZhu
Baixing eDing
Xiaogang eXu
Demei eZhu
fan eYang
Hong eZhang
Fupin eHu
Klebsiella pneumoniae: development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumonia
Frontiers in Microbiology
in vivo
Klebsiella pneumoniae;
NDM-1 Metallo--Lactamase;
Development of Carbapenem Resistance;
Meropenem;
title Klebsiella pneumoniae: development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumonia
title_full Klebsiella pneumoniae: development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumonia
title_fullStr Klebsiella pneumoniae: development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumonia
title_full_unstemmed Klebsiella pneumoniae: development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumonia
title_short Klebsiella pneumoniae: development of carbapenem resistance due to acquisition of blaNDM-1 during antimicrobial therapy in twin infants with pneumonia
title_sort klebsiella pneumoniae development of carbapenem resistance due to acquisition of blandm 1 during antimicrobial therapy in twin infants with pneumonia
topic in vivo
Klebsiella pneumoniae;
NDM-1 Metallo--Lactamase;
Development of Carbapenem Resistance;
Meropenem;
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01399/full
work_keys_str_mv AT junyingezhu klebsiellapneumoniaedevelopmentofcarbapenemresistanceduetoacquisitionofblandm1duringantimicrobialtherapyintwininfantswithpneumonia
AT baixingeding klebsiellapneumoniaedevelopmentofcarbapenemresistanceduetoacquisitionofblandm1duringantimicrobialtherapyintwininfantswithpneumonia
AT xiaogangexu klebsiellapneumoniaedevelopmentofcarbapenemresistanceduetoacquisitionofblandm1duringantimicrobialtherapyintwininfantswithpneumonia
AT demeiezhu klebsiellapneumoniaedevelopmentofcarbapenemresistanceduetoacquisitionofblandm1duringantimicrobialtherapyintwininfantswithpneumonia
AT faneyang klebsiellapneumoniaedevelopmentofcarbapenemresistanceduetoacquisitionofblandm1duringantimicrobialtherapyintwininfantswithpneumonia
AT hongezhang klebsiellapneumoniaedevelopmentofcarbapenemresistanceduetoacquisitionofblandm1duringantimicrobialtherapyintwininfantswithpneumonia
AT fupinehu klebsiellapneumoniaedevelopmentofcarbapenemresistanceduetoacquisitionofblandm1duringantimicrobialtherapyintwininfantswithpneumonia